Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 70518-3484

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 70518-3484). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for diltiazem hydrochloride extended-release capsules, 120 mg strength, packaged in a quantity of 30 capsules. The label displays the proprietary name, dosage form, strength, quantity, and repackager RemedyRepack Inc. It includes the NDC number 70518-3484 and manufacturer details from Ingenus, Fairfield, NJ.*

FDA Label Image

Image (Image 01)

Chemical structure of diltiazem hydrochloride showing the molecular arrangement with labeled chemical groups including OCH3, HCl, and others.*

FDA Label Image

Image (Image 02)

Data table comparing adverse reactions in placebo-controlled angina and hypertension trials for diltiazem hydrochloride extended-release capsules 120 mg. It presents percentages of patients experiencing headache, dizziness, bradycardia, AV block first degree, edema, and asthenia in groups taking diltiazem hydrochloride extended-release capsules versus placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.